Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dr. Reddy’s Launches Debiopharm’s Pamorelin® LA in India

Published: Friday, December 07, 2012
Last Updated: Friday, December 07, 2012
Bookmark and Share
Pamorelin® LA for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Debiopharm Group™ (Debiopharm) has announced that Dr. Reddy’s Laboratories Ltd. has launched Pamorelin® LA in India for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer on December 3.

Under the terms of the agreement, Dr. Reddy’s acquires exclusive marketing and sales rights for Pamorelin® LA Depot in India.

The product is exported in bulk from Debio Recherche Pharmaceutique (Debio R.P.) to Dr. Reddy’s.

Pamorelin® LA will be made available primarily to urologists and oncologists across India.

‘We recognize the need for prostate cancer treatment in India and are thrilled to have the opportunity to bring Pamorelin® LA to Indian patients’, said Rolland-Yves Mauvernay, President and founder of Debiopharm Group™.

Mauvernay continued, ‘This major step enables us to implement our strategy in one of the most important markets in Asia. This is only the logical continuation to a harmonious working relationship shared with Dr. Reddy’s over the years.’

Dr. Reddy’s and Debiopharm share the same vision to bring high-quality and safe ethical products to the highest number of patients suffering from serious diseases in India.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Debiopharm Group™ Presents The ‘JCA Mauvernay Award 2013’
Doctors Kitabayashi and Yano will receive awards during the General Assembly of the 72nd Annual Conference of the JCA in Yokohama.
Tuesday, October 08, 2013
Curis and Debiopharm Announce Initiation of Phase I-II Clinical Study of HSP90 Inhibitor
Study to test Debio 0932 in patients with advanced non-small cell lung cancer.
Friday, August 17, 2012
Debiopharm and Vifor Pharma Sign an Exclusive Agreement
Distribution and commercialization of Pamorelin® LA in Switzerland.
Monday, May 21, 2012
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
Enlisting Insects to Protect Agriculture
New program aims for insect delivery of protective genes to modify mature plants within a single growing season.
New Mechanism of Plant RNA Degradation Identified
Researchers have identified a novel mechanism by which RNA is degraded.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Questioning the Safety of Selenium to Combat Cancer
Research indicates the need for change in practice as selenium supplements cannot be recommended for preventing colorectal cancer.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Leukaemia Cell Movement Gives Clues to Tackling Treatment-Resistant Disease
Researchers at Imperial College London have suggested that the act of moving itself may help the cells to survive, possibly through short-lived interactions with an array of our own cells.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos